Semaglutide may increase risk for nonarteritic anterior ischemic optic neuropathy
Medical Xpress - medical research advances and health news [Uno…
February 23, 2026
People with type 2 diabetes starting semaglutide have more than a doubled risk for nonarteritic anterior ischemic optic neuropathy (NAION) versus those starting sodium-glucose cotransporter-2 inhibitors (SGLT2is), according to a brief report published online Feb. 12 in JAMA Ophthalmology.
Discussion in the ATmosphere